Calamos Advisors’s C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant CXAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-300,000
Closed -$3.07M 1404
2022
Q3
$3.07M Hold
300,000
0.01% 790
2022
Q2
$3M Hold
300,000
0.01% 838
2022
Q1
$3.03M Buy
+300,000
New +$3.02M 0.01% 830

Other funds holding CXAC.U

Calamos Advisors's CXAC.U Position: Q4 2022 in Review

Calamos Advisors sold out of C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant (CXAC.U) in Q4 2022, closing a stake of 300,000 shares — an estimated $3.07M sold.

Calamos Advisors first reported a position in CXAC.U in Q1 2022 and held it in 3 quarters. The position peaked at $3.07M in Q3 2022. 18 funds tracked by Wall St. Rank hold CXAC.U as of Q4 2022.

  • Calamos Advisors reported no remaining C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 300,000 C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant shares in Q4 2022, an estimated $3.07M.
  • Calamos Advisors first reported a position in C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant in Q1 2022 and held it in 3 quarters.
  • Calamos Advisors's C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position peaked at $3.07M in Q3 2022.
  • 18 funds tracked by Wall St. Rank held C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.